News (22)

Vaccine-induced prothrombotic immune thrombocytopenia: pathogenetic and epidemiological issues of concern AQ
Transcript : Innate Pharma S.A., H1 2020 Earnings Call, Sep 08, 2020
Tikehau Capital : Universal Registration Document and half year financial report as at 30 June 2019 PU
Tikehau Capital : Assets under management of €23.4 billion at 30 June 2019, up 6% over the first-half and 16% over the last 12 months PU
Tikehau Capital: Assets under management of €23.4 billion at 30 June 2019, up 6% over the first-half and 16% over the last 12 months BU
Tikehau Capital : Appoints Laure Perréard as Chief Financial Officer BU
Tikehau Capital Announces Executive Changes CI
BPCE : pierre Valentin elected Chairman of the Supervisory Board of Groupe BPCE GL
Banque de France : Working Papers n° 533 - Capital Regulation in a Macroeconomic Model with Three Layers of Default. PU
Banque de France : Working Papers n° 530 - Land Collateral and Labor Market Dynamics in France PU
Banque de France : Working Papers n° 528 - Assessing the macroeconomic effects of LTROS PU
Banque de France : Working Papers n° 526 - Trade networks and colonial trade spillovers PU
Banque de France : Working Papers n° 525 - How Fiscal Policy Affects the Price Level: Britain’s First Experience with Paper Money PU
Banque de France : Working Papers n° 523 - How do oil price forecast errors impact inflation forecast errors? An empirical analysis from French and US inflation forecasts PU
Banque de France : Working Papers n° 522 - Euro Area business cycles in turbulent times: convergence or decoupling? PU
Banque de France : Working Papers n° 520 - Variable Selection in Predictive MIDAS Models PU
Banque de France : Working Papers n° 519 - Pre-crisis credit standards: monetary policy or the savings glut? PU
Banque de France : Working Papers n° 518 - Options Embedded in ECB Targeted Refinancing Operations PU
Banque de France : Working Papers n° 514 - Product and Labor Market Regulations, Production Prices, Wages and Productivity (copie 1) PU
Banque de France : Working Papers n° 512 - Euro Area monetary policy shocks: impact on financial asset prices during the crisis? PU
Banque de France : Working Papers n° 511 - Economic Policy Uncertainty and Inflation Expectations PU
Fairway Project Operations Update PU

Companies (13)

VERU INC. 148 M $
Logo Veru Inc.

Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the manag ...

ARD GRUP BILISIM TEKNOLOJILERI ANONIM SIRKETI 190 M $
Logo Ard Grup Bilisim Teknolojileri Anonim Sirketi

Ard Grup Bilisim Teknolojileri AS is a Turkey-based information technology (IT) company. It focuses on architecture implementation, software development, and cyber security providing customizable products and services. Its offering includes a wide range o ...

MEDICINOVA, INC. 67 M $
Logo MediciNova, Inc.

MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activiti ...

TALPHERA, INC. 18 M $
Logo Talphera, Inc.

Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidate ...

PARADIGM BIOPHARMACEUTICALS LIMITED 58 M $
Logo Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) ...

BIOCARDIA, INC. 127 M $
Logo BioCardia, Inc.

BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous monon ...

AVALO THERAPEUTICS, INC. 12 M $
Logo Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Its pipeline also includes quisovalimab (AVTX-0 ...

MESOBLAST LIMITED 841 M $
Logo Mesoblast Limited

Mesoblast Limited is an Australia-based is developing a range of late-stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. The Company’s Remestemcel-L is mesenchymal lineage stromal cell product pl ...

EDESA BIOTECH, INC. 14 M $
Logo Edesa Biotech, Inc.

Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. The Company’s advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for ...

ARGENT BIOPHARMA LIMITED 11 M $
Logo Argent BioPharma Limited

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologi ...

PEAK BIO, INC. 198 874 $
Logo Peak Bio, Inc.

Peak Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on commercializing therapeutics that aim to improve and address unmet medical needs for patients with inflammatory, rare and specialty diseases and cancer. The Company’ ...

INCANNEX HEALTHCARE INC. 45 M $
Logo Incannex Healthcare Inc.

Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...

ADVANCED LIFE SCIENCES HOLDINGS, INC. 107 880 $
Logo Advanced Life Sciences Holdings, Inc.

Advanced Life Sciences Holdings, Inc. is a United States-based biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, cancer, and respiratory diseases. The Com ...


12Next

Insiders

Picture Laure Frères
Laure Frères

Ms. Laure Frères is an Executive Vice President, Head-Quality & Medical at Orpea SA.


Picture Laure Perréard
Laure Perréard

Currently, Laure Perréard holds the position of Chief Financial Officer of Tikehau Capital SCA.


Picture Laure Duhot
Laure Duhot

Laure Duhot currently holds several positions as an Independent Non-Executive Director at Safestore Holdings Plc, NB Global Monthly Income Fund Ltd., Primary Health Properties Plc, and Non-Executive Director at Safestore Ltd.
She is also a Director at Lifestory Group Ltd.
and a Managing Director at Duhot-Consult Ltd.
In the past, she held positions as Managing Director at Grainger Plc from 2012 to 2016, Independent Non-Executive Director at MXF Fund Ltd., Independent Non-Executive Director at Inland Homes PLC from 2018 to 2020, Independent Director at Orpea SA from 2022 to 2023, and Non-Executive Director at Thames Valley Housing Association Ltd.
She also worked as Head-Investment & Capital Markets-Europe at Lendlease Group.








Picture Laure Roberts Swift
Laure Roberts Swift

Laure Roberts Swift served as Vice President-Human Resources Europe at Air Products & Chemicals, Inc. She then worked as Head-Human Resources at Syngenta AG from 2011 to 2020.
She earned an MBA from the University of Aston in 1985 and completed her undergraduate degree at ESCP Europe Campus Paris.





Picture Laure Penchinat
Laure Penchinat

Ms. Laure Penchinat is Secretary & Director at Société des Lecteurs du Monde SA. She is on the Board of Directors at Société des Lecteurs du Monde SA. She received her undergraduate degree from the Institut National des Langues & Civilisations Orientales.






Picture Laure Hauseux
Laure Hauseux

Laure Hauseux is currently a Director at Plastiques du Val de Loire SA, OGF SA, and an Independent Director at Maisons du Monde SA and Fnac Darty SA. She is also a Member-Supervisory Board at Pomona SA, a Member-Management Board at Obol France 1, and a Manager at Sci Le Nid.
In the past, she has worked as a Deputy Chief Executive Officer at Conforama Italia SpA, Chief Executive Officer at GAC SASU, Deputy Director General at Virgin Stores SA, Store Manager at Fnac Direct SASU, and Chief Financial Officer at Printemps SASU.
She has also served as an Independent Director at Casino, Guichard-Perrachon SA and Zodiac Aerospace SA. She holds an MBA from INSEAD and ESCP Europe, and an undergraduate degree from Université Paris Dauphine-PSL.




Picture Laure Heriard-Dubreuil
Laure Heriard-Dubreuil

Laure Heriard-Dubreuil is the founder of 1220 Collins Avenue, Inc. She is currently the Chairman of Laure HD Investissements SAS and a Director at Rémy Cointreau SA. Ms. Heriard-Dubreuil has an undergraduate degree from the Fashion Institute of Technology and another undergraduate degree from the Institut National des Langues & Civilisations Orientales.





Picture Laure Oriez
Laure Oriez

Ms. Laure Oriez is a Head of Compliance at Trusteam Finance SCA.
She joined the firm in 2013.
She was a discretionary portfolio manager at Compagnie Internationale de Banque before becoming a mutual fund manager in charge of fixed-income management and employee savings funds at Monte Paschi Banque from 1987.
In 2004, she became Deputy Director at Monte Paschi Invest in charge of regulatory and control matters, and then held the post of Managing Director from 2009 to 2012.
She is a chemical engineer by training (at the INSCI Rouen) and the holder of an MBA at EM Lyon (CESMA).






Picture Laure Négiar
Laure Négiar

Ms. Laure Négiar, CFA, is an Analyst & Portfolio Manager at Comgest SA. She joined Comgest in 2010 and is an Analyst and Portfolio Manager specialising in Global equities.
She is also a non-executive member of the Board of Partners and the Global Equity Team manager.
She co-manages Comgest's Global and EAFE (Global ex-US) strategies as well as the team’s segregated accounts.
Before joining Comgest, she worked at BNP Paribas Equities & Derivatives in Paris and London, and prior to that worked in several roles within the US government.
She obtained a Bachelor’s degree in Public Policy from Stanford University (with Honours and Phi Beta Kappa) before graduating on the Dean's list with an MSc in Management from the HEC business school in France.


















Picture Laure Chevrillon
Laure Chevrillon

Laure Chevrillon has worked as an Investment Manager at Chevrillon & Associés SCA since 2015.




Picture Laure Fau
Laure Fau

Laure Fau currently works as a Director at Famille Mommessin SA.



Picture Laure Morsy
Laure Morsy

Laure Morsy is currently a Director at BNP Paribas UK Holdings Ltd.
and BNP Paribas Lease Group SA Zweigniederlassung Deutschland.
Previously, Mr. Morsy worked as the Chief Operating Officer & Head-Corporate Banking at BGL BNP Paribas SA.



Picture Laure Levin
Laure Levin

Laure Levin currently works at Modular Robotics, Inc., as Vice President-Sales.



Picture Laure Genet
Laure Genet

Laure Genet worked as an Analyst at SG Securities (Paris) SAS from 2011 to 2016.
She also worked as an Analyst at Société Générale SA (Broker).




Picture Marjan Laure
Marjan Laure

Marjan Laure currently works as a Sales Manager at ES Energy Save Holding AB.


Picture Laure Carladous
Laure Carladous

Laure Carladous currently holds the position of Chairman at Société Travaux Constructions Materiaux.
She is currently working as a Director at Société Mutuelle d'Assurance du BTP, where she started in 2020.





Picture Laure Poty
Laure Poty

Laure Poty worked as a Director of Group Communications at ID Logistics Group.


Picture Laure Delaquaize
Laure Delaquaize

Laure Delaquaize is associated with three different organizations.
She is currently serving as the Chairman of Cl de Melun and Vice Chairman of Association Point Passerelle.
In addition, she is also working as a Director at Caisse Régionale De Crédit Agricole Mutuel Brie Picardie since 2019.


Picture Laure Canivet Donsimoni
Laure Canivet Donsimoni

Laure Canivet Donsimoni has worked as a Credit Portfolio Manager at Amundi Asset Management SA (Investment Management) since 2014.



Picture Laure Fouin
Laure Fouin

Laure Fouin currently works at McCarthy Tétrault LLP ( Canada), as Partner.




Picture Laure Michel
Laure Michel

Laure Michel is currently a Director at McPhy Energy SA, Nenuphar SA, Technologgia SAS, NAWATechnologies SA, Apix Analytics SA, eLichens SAS, Pili SAS, DCbrain SAS, and Green Impulse SAS.
She is a former Chief Executive Officer at Secant, Inc. Michel has an undergraduate degree from Université Pierre et Marie Curie and another undergraduate degree from Institut d’Administration des Entreprises.




Picture Laure Hurbin
Laure Hurbin

Laure Hurbin has worked as a Director at Nexans Maroc SA since 2016.





Picture Laure Arnon-Duquesnoy
Laure Arnon-Duquesnoy

Laure Arnon-Duquesnoy is currently a Partner at August & Debouzy.







Picture Laure Geffroy
Laure Geffroy

Laure Geffroy has a current job as Director of Human Resources at Bio-UV Group SA.


Picture Laure Muneret
Laure Muneret

Laure Muneret currently works at Mon Courtier Energie Groupe SA, as Manager-Customer Service.









Picture Laure Belluzzo
Laure Belluzzo

Laure Belluzzo is currently the Chairman at Progica, and a Director at both CA Consumer Finance SA and Crédit Agricole Consumer Finance SA. Previously, he was the Head-Audit at Crédit Lyonnais SA from 2008 to 2016.





Picture Laure Desbrosses
Laure Desbrosses

Laure Desbrosses is a Senior Credit analyst at LBP AM since 2022.
Prior to this, she worked as a Senior Credit Analyst at Allianz Global Investors GmbH (France) from 2013 to 2021.
Before that, she was a Research Analyst at Oddo BHF SCA (Broker) from 2011 to 2012.
Additionally, she worked as a Vice President at CBAM SAS in 2022.



No results for this search